EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:753623 - dupilumab
| ChEBI ID | CHEBI:753623 |
| ChEBI Name | dupilumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| dupilumab (CHEBI:753623) has role anti-asthmatic agent (CHEBI:65023) |
| dupilumab (CHEBI:753623) has role anti-inflammatory agent (CHEBI:67079) |
| dupilumab (CHEBI:753623) has role antineoplastic agent (CHEBI:35610) |
| dupilumab (CHEBI:753623) has role antiviral agent (CHEBI:22587) |
| dupilumab (CHEBI:753623) has role dermatologic drug (CHEBI:50177) |
| dupilumab (CHEBI:753623) has role ophthalmology drug (CHEBI:66981) |
| dupilumab (CHEBI:753623) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Dupilumab | ChEMBL |
| REGN-668 | ChEMBL |
| REGN668 | ChEMBL |
| SAR-231893 | ChEMBL |
| SAR231893 | ChEMBL |
| Brand Names | Source |
|---|---|
| Dupixent | ChEMBL |
| Regn668, sar231893 | ChEMBL |